CVS Health (NYSE: CVS) reported Q2 EPS of $2.40, $0.22 better than the analyst estimate of $2.18. Revenue for the quarter came in at $80.6 billion versus the consensus estimate of $76.4 billion.

GUIDANCE:

CVS Health sees FY2022 EPS of $8.40-$8.60, versus prior of $8.20-$8.40 and the consensus of $8.36.

For earnings history and earnings-related data on CVS Health (CVS) click here.